Top Markets
Coin of the day
Avivagen Inc. Avivagen Inc.

Avivagen Inc.

VIV
Rank in Stocks #40244
Avivagen Inc. is a life sciences enterprise that invents and sells specialized... Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity. The company's diverse product lineup features OxC-beta Livestock, a crucial premix for farm animal diets. Beyond agriculture, Avivagen also manufactures health supplements such as Vivamune and Dr. Tobias-branded chews for dogs, along with the Dr. Tobias Beta blend, formulated to support human immunity. Established in 2005 and based in Ottawa, Canada, Avivagen Inc. distributes its offerings across numerous international markets, including the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia.
Share Price
$0.00368316
Last synced: 2024-03-04
Market Cap
$199.43K
Change (1 day)
0.05%
Change (1 year)
0.00%
Country
CA
Trade Avivagen Inc. (VIV)

Category

Earnings for Avivagen Inc. (VIV)
Earnings in 2026 TTM: 0
According to Avivagen Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Avivagen Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors